Washington, DC (AP) - Novavax has received $1.6 billion from the federal government to complete late-stage clinical development, establish large-scale manufacturing, and deliver 100 million doses of its COVID-19 vaccine candidate.
The vaccine could be delivered as soon as later this year.
Regeneron Pharmaceuticals has received $450 million through Operation Warp Speed to make and supply its COVID-19 vaccine candidate.
The Environmental Protection Agency is starting to approve surface disinfectant products tested on the virus.
The agency said that it’s approved two products, Lysol Disinfectant Spray and Lysol Disinfectant Max Cover Mist, based on laboratory testing that shows the products are effective against SARS-CoV-2.